Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Allergan's Botox approved for hyperhidrosis in the U.K.

Aug. 22, 2001

Agreement to commercialize Anogesic announced by Cellegy and Ventiv

Aug. 22, 2001

Clinical program for Vitrix living dermal replacement begins

Aug. 14, 2001

Desloratadine approved in the E.U. for symptoms of chronic idiopathic urticaria

Aug. 13, 2001

Final results of PH-10 pilot study in the treatment of plaque psoriasis reported

Aug. 10, 2001

Simultaneous filing of a Common Technical Document for Amevive in the U.S. and Europe

Aug. 8, 2001

Allergan expands dermatology collaboration with Cytochroma

Aug. 8, 2001

MBI-594AN phase II clinical trial for acne completes enrollment

Aug. 6, 2001

Results from pivotal phase III trials on Xanelim for psoriasis presented

Aug. 2, 2001

Biogen's Amevive shows good results as therapy for psoriasis

Aug. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...